The Science

An Idea was Born

Invented by Kevin J. Cady, the idea for the AccuraSee™  Intraocular Pseudophakic Contact Lens (IOPCL) came from years of paying witness to the ophthalmic surgeon’s struggle to deliver a minimally-invasive surgical solution to “fine-tune” the refractive outcome of the pseudophakic patient, without compromising vision quality.

The AccuraSee™ IOPCL is a neutral spherical optic made of biocompatible tested silicone (Biosil™). The AccuraSee IOPCL is designed to share the space, auto-center and securely couple with any pre-existing IOL in the eyes capsular bag, without the inherent risk associated with sulcus placed lens platforms (e.g.,  recurrent iridocyclitis, uveitis-glaucoma-hyphemia (UGH) syndrome, vitreous hemorrhage, cystoid macular edema, et cetera).

Although originally designed to adjust the refractive error in the pseudophakic eye, the AccuraSee™ IOPCL platform can be customized to allow for astigmatic correction, cornea asymmetry, multifocality as well as low vision. It is also fully reversable for either refractive power adjustment or multifocal reversibility.

Introducing the the AccuraSee™ IOPCL AMD Mag! This novel lens technology is specially designed to deliver an unsurpassed level of magnified vision for the pseudophakic patient who suffers from low vision, most specifically, advanced stage age related macular degeneration (AMD). The lens will serve as a near magnifier for the patient when the patient’s pupil both constricts and converges. The peripheral area of the optic refractive power is neutral so light rays in this zone are unchanged at distance.

President & CEO

Kevin Cady is the CEO and Founder of OnPoint Vision™, a refractive company that designs, develops & manufactures intraocular lens implants, most specifically the AccuraSee™ Intraocular Pseudophakic Contact Lens (AKA: CadyLens) designed to fine-tune the refractive error of the pseudophakic eye as well as deliver vision recovery for patients who have experienced a decline in vision due to age-related retinal pathologies.  Prior to forming OnPoint Vision™, Mr. Cady joined Refocus Group in 2015 as Vice President of Marketing & Business Development. From 2011 to 2014, Mr. Cady was the Regional Business Director for WaveTec Vision Systems, where he was responsible for the marketplace expansion of the Optiwave Refractive Analysis (ORA) system to ophthalmic surgeons. Prior to joining WaveTec Vision Systems, Mr. Cady was the Area Vice President of Sales for Bausch Lomb Surgical, after the company acquired Eyeonics. Mr. Cady has over 30 years in the ophthalmic industry theatre with extensive knowledge and experience in both the development of ophthalmic pharmacologic agents and medical device product line.

Mr. Cady has a Bachelor of Science Degree in Economics from Illinois State University. He is credentialed with over 35 patents worldwide with the  invention of the CadyLens, an Intraocular Pseudophakic Contact Lens (IOPCL) as well as related surgical instruments and medical devices.